Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark L Rolfsen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Critical Care Medicine|June 13, 2024
Cognitive Impairment in the PROSPECT ModelMark L Rolfsen, E Wes Ely
Chest|February 12, 2025
What's the "Get to Know Me Board"?Mark L Rolfsen, E Wesley Ely
Critical Care Clinics|October 16, 2025
Optimal Sedation in Older Critically Ill AdultsMark L Rolfsen, Christina Boncyk, Robert L Owens, et al.
Chest|February 1, 2025
Communicating to Patients and Families About Post-Intensive Care SyndromeMark L Rolfsen, M Elizabeth Wilcox, Matthew F Mart, et al.
BMJ (Clinical Research Ed.)|December 9, 2024
Management of pain and sedation in the intensive care unitChristina Boncyk, Mark L Rolfsen, David Richards, et al.
Critical Care Explorations|July 5, 2022
Association Between Acute Kidney Injury During Invasive Mechanical Ventilation and ICU Outcomes and Respiratory System MechanicsSneha V Vemuri, Mark L Rolfsen, Alexandra V Sykes, et al.
Chest|October 11, 2025
Post-Intensive Care Syndrome Awareness and Communication: Surveys of ICU Providers and PatientsMark L Rolfsen, Matthew F Mart, Hannah Kieffer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 14, 2022
Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissionsMark L Hepokoski, Mazen Odish, Michael T Lam, et al.
JCI Insight|December 8, 2025
Kidney mitochondrial DNA contributes to systemic IL-6 release in sepsis-associated acute kidney injuryAvnee J Kumar, Katharine Epler, Jing Wang, et al.
The Lancet. Respiratory Medicine|May 3, 2024
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trialMatthew F Mart, Leanne M Boehm, Amy L Kiehl, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Critical Care Medicine|June 13, 2024
Cognitive Impairment in the PROSPECT ModelMark L Rolfsen, E Wes Ely
Chest|February 12, 2025
What's the "Get to Know Me Board"?Mark L Rolfsen, E Wesley Ely
Critical Care Clinics|October 16, 2025
Optimal Sedation in Older Critically Ill AdultsMark L Rolfsen, Christina Boncyk, Robert L Owens, et al.
Chest|February 1, 2025
Communicating to Patients and Families About Post-Intensive Care SyndromeMark L Rolfsen, M Elizabeth Wilcox, Matthew F Mart, et al.
BMJ (Clinical Research Ed.)|December 9, 2024
Management of pain and sedation in the intensive care unitChristina Boncyk, Mark L Rolfsen, David Richards, et al.
Critical Care Explorations|July 5, 2022
Association Between Acute Kidney Injury During Invasive Mechanical Ventilation and ICU Outcomes and Respiratory System MechanicsSneha V Vemuri, Mark L Rolfsen, Alexandra V Sykes, et al.
Chest|October 11, 2025
Post-Intensive Care Syndrome Awareness and Communication: Surveys of ICU Providers and PatientsMark L Rolfsen, Matthew F Mart, Hannah Kieffer, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 14, 2022
Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissionsMark L Hepokoski, Mazen Odish, Michael T Lam, et al.
JCI Insight|December 8, 2025
Kidney mitochondrial DNA contributes to systemic IL-6 release in sepsis-associated acute kidney injuryAvnee J Kumar, Katharine Epler, Jing Wang, et al.
The Lancet. Respiratory Medicine|May 3, 2024
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trialMatthew F Mart, Leanne M Boehm, Amy L Kiehl, et al.
Pageof 1